Morphological findings in non-episode biopsies of kidney transplant allografts treated with FK506 or cyclosporine

Transplant International

Volumn 11, Issue SUPPL. 1, 1998, Pages

  Kyo, Masahiro ^a   Hatori, Motoaki ^b   Takahara, Shiro ^c   Kyakuno, Miyaji ^d   Nakamura, Takayuki ^d   Okada, Masanao ^d   Kokado, Yukito ^c   Toki, Kiyohide ^c   Ding, Xiao Qlang ^c   Miki, Tuneharu ^c   Miyamoto, Makoto ^c   Okuyama, Akihiko ^c  

^a Sakurabashi Circulate Organ Clinic 1100   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d Osaka Senninhoken Hospital   (Japan)

Author keywords

Cyclosporin; Drug induced arteriolopathy; Non episode biopsy; Tacrolimus

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTICLE; BIOPSY; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; HUMAN; KIDNEY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; PATHOLOGY; POSTOPERATIVE COMPLICATION; VASCULAR DISEASE; VASCULARIZATION;

BIOPSY; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TACROLIMUS; VASCULAR DISEASES;

EID: 0031613687     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1998.tb01089.x     Document Type: Article

References (10)

1. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A (1989) FK506 for liver, kidney and pancreas transplantation. Lancet 28: 1000-1004
2. Gjertson DW, Cecka JM Terasaki PI (1995) The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation 60: 1384-1388
3. Shapiro R, Jordan ML, Scantlebury VP, et al (1995) A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 59: 485-490
4. Japanese FK506 Study Group (1994) Long-term FK506 (tacrolimus) therapy in kidney transplantation. Transplantat Japonica 29: 632-649
5. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J (1994) Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57: 208-211
6. Rush DN, Jeffery JR, Gough J (1995) Sequential protocol biopsies in renal transplant recipients - clinicopathological correlations using Banff schema. Transplantation 59: 511-514
7. Mihatsch MJ, Antonoych T, Bohman SO, et al (1994) Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies. Clin Nephrol 41: 23-32
8. Takeda A, Morozumi K, Uchida K, et al (1993) Is cyclosporine-associated glomerulopathy a new glomerular lesion in renal allografts using CyA? Transplant Proc 25: 515-517
9. Morozumi K, Thiel G, Albert FW, Banfi G, Gudat F, Mihatsch MJ (1992) Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts. Clin Nephrol 38: 1-8
10. Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris A (1993) The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506: clinical significance and comparison with cyclosporine. Am J Surg Pathol 17: 60-68